Dissolving microneedles: safety considerations and future perspectives.

about

Considerations in the use of microneedles: pain, convenience, anxiety and safety.Transdermal delivery of vitamin K using dissolving microneedles for the prevention of vitamin K deficiency bleeding.

P2860

Q38860500-4D1F6507-B32C-4DBB-AE38-5C734DBC0C8F Q55079183-EFED4DE7-1BF7-449E-9AC9-7B5A5BDC89D1

P2860

Dissolving microneedles: safety considerations and future perspectives.

Item

http://www.wikidata.org/entity/Q48146241

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Dissolving microneedles: safety considerations and future perspectives.

@en

Dissolving microneedles: safety considerations and future perspectives.

@nl

type

Item

label

Dissolving microneedles: safety considerations and future perspectives.

@en

Dissolving microneedles: safety considerations and future perspectives.

@nl

prefLabel

Dissolving microneedles: safety considerations and future perspectives.

@en

Dissolving microneedles: safety considerations and future perspectives.

@nl

P1476

Dissolving microneedles: safety considerations and future perspectives

@en

P2093

Helen L Quinn

http://www.w3.org/2001/XMLSchema#string

Ryan F Donnelly

http://www.w3.org/2001/XMLSchema#string

P2860

Microneedles for intradermal and transdermal drug delivery

Polymer microneedles for controlled-release drug delivery.

Microneedle arrays allow lower microbial penetration than hypodermic needles in vitro.

Hydrogel-forming microneedle arrays exhibit antimicrobial properties: potential for enhanced patient safety.

Administration, distribution, metabolism and elimination of polymer therapeutics.

Current advances in the fabrication of microneedles for transdermal delivery.

Microneedle characterisation: the need for universal acceptance criteria and GMP specifications when moving towards commercialisation.

Clinical study and stability assessment of a novel transcutaneous influenza vaccination using a dissolving microneedle patch.

Dissolving polymeric microneedle arrays for electrically assisted transdermal drug delivery.

In vitro and in vivo study of thymosin alpha1 biodegradable in situ forming poly(lactide-co-glycolide) implants.

P304

283-285

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.4155/TDE-2016-0015

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Eneko Larrañeta

P577

2016-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27075949

http://www.w3.org/2001/XMLSchema#string

Dissolving microneedles: safety considerations and future perspectives.

about

P2860

P2860

Dissolving microneedles: safety considerations and future perspectives.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698